SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Grandy who wrote (493)3/17/1997 3:23:00 AM
From: John Grandy   of 6136
 
JIM MCCAMANT JUST RATED AGPH A BUY AT CURRENT LEVELS

jim mccamant the worlds leading expert on biotechnology stocks has reversed his sell-on-the-news recommend and now rates agph a "trading buy" at 80. on feb 20 he thought the stock would be 100-110 at time of approval and so recommended partial profit taking. he regrets this decision. he now rates agph a strong hold and a trading buy.

JOIN ME AND KILL THE SHORTS. ITS ALL OVER FOR THEM IF WE GET THE WORD OUT. GOT TO AOL AND POST. GO EVERYWHERE AND POST. CALL ALL YOUR FRIENDS. TELL YOUR BROKER.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext